Impact of pituitary suppression on antral follicle count and oocyte recovery after ovarian stimulation
Tuesday, March 1, 2016We discuss how short-term pituitary suppression decreases antral follicle count.
Tuesday, September 29, 2015New automated AMH assays provide substantially lower values than existing AMH enzyme-linked immunosorbent assays. Assay-specific interpretation is necessary, along with international standardization.
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth
Thursday, July 30, 2015Personalized prediction of live-birth prognosis incorporating baseline clinical characteristics and antimullerian hormone can be achieved at a center specific level, with no added value from incorporating antral follicle count.
Comparison of markers of ovarian reserve between patients with complete mullerian agenesis and age matched fertile and infertile controls
Monday, June 29, 2015This study investigated ovarian reserve in complete mullerian agenesis (CMA) patients and compared the ovarian reserve of CMA patients with age-matched fertile and infertile controls.
Second surgery for recurrent unilateral endometriomas and impact on ovarian reserve A case control study
Wednesday, April 29, 2015Laparoscopic stripping of recurrent ovarian endometriomas decreases antimullerian hormone levels, increases basal FSH, and decreases the antral follicle count and volume of the operated ovary.
Wednesday, April 29, 2015Reflections on "Does antral follicle count (AFC) predict pregnancy rates in unstimulated therapeutic donor insemination (TDI) cycles?" by Ripley et al.
Role of ovarian reserve markers antimüllerian hormone and antral follicle count as aneuploidy markers in ongoing pregnancies and miscarriages
Wednesday, April 29, 2015Antral follicle count appears to reflect the risk of autosomal trisomy better than maternal age. In contrast, antimullerian hormone does not deviate from the expected maternal age levels.
Wednesday, April 29, 2015Antral follicle count is not predictive of pregnancy or miscarriage in patients undergoing unstimulated therapeutic donor insemination cycles for indications of an azoospermic male partner or the absence of a male partner.
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good prognosis patients at individual fertility clinics in two multicenter trials
Monday, March 30, 2015Antimullerian hormone was a stronger predictor of ovarian response to controlled ovarian stimulation than AFC in both GnRH agonist and antagonist cycles, also when data were evaluated at the study center level.
Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool
Monday, March 30, 2015An automated antimullerian hormone assay showed good correlations with age and antral follicle count and is a reproducible measure of the growing follicle pool.
Friday, February 27, 2015
Practice Committee of the American Society for Reproductive Medicine
Volume 103, Issue 3, Page e9
Currently there is no uniformly accepted definition of decreased ovarian reserve (DOR), as the term may refer to three related but distinctly different outcomes: oocyte quality, oocyte quantity, or reproductive potential.…